407 Studies Now Enrolling
Feasibility Study of Synbiotic Therapy for Neuropsychiatric PASC
Synbiotic Therapy for NP-PASC - Improving Gut Health for Long COVID Symptoms
| Sponsor: | Unfunded |
| Enrolling: | Male and Female Patients |
| Study Length: | 4 Weeks |
| Clinic Visits: | 2 |
| IRB Number: | AAAV3630 |
| U.S. Govt. ID: | NCT06620406 |
| Contact: | Jayesh Shah: / jgs2142@cumc.columbia.edu |
Additional Study Information:
A study looking at improving gut health and cognitive symptoms in Long COVID patients. A 4-week study taking a prebiotic (fiber) with a probiotic bacteria (Synbiotic). The study involves 2 in-person study visits which involves online surveys, cognitive testing, blood samples, stool samples, and rectal swab samples. Each completed study visit pays you $80 in the form of a paycard.
Do You Qualify?
| After infection with SARS-COV2, did you experience ongoing fatigue, cognitive impairment, or orthostatic intolerance? | Yes | No |
| Are you currently taking probiotics, prebiotics, fiber supplements, antibiotics, immunomodulatory or immunosuppressive drugs? | Yes | No |
| Do you have a history of liver cirrhosis, inflammatory bowel disease, or other major conditions related to the colon? | Yes | No |
| Do you have an allergy to probiotics, prebiotics, or fibers? | Yes | No |
| Do you have a serious illness that required entry to the hospital anytime with the last 30 days? | Yes | No |